Diagnostic accuracy of pcr in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: A 2-year longitudinal study

PLoS Neglected Tropical Diseases

Volumn 5, Issue 2, 2011, Pages

  Deborggraeve, Stijn ^a,b   Lejon, Veerle ^a   Ekangu, Rosine Ali ^a,c   Ngoyi, Dieudonné Mumba ^a,c   Pyana, Patient Pati ^a,c   Ilunga, Médard ^d   Mulunda, Jean Pierre ^d   Büscher, Philippe ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c Direction of the institute   (Democratic Republic Congo)

^d Programme National de Lutte contre la Trypanosomiase Humaine Africaine   (Democratic Republic Congo)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN TRYPANOSOMIASIS; ARTICLE; BLOOD; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FOLLOW UP; GENE TARGETING; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MICROORGANISM DETECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RNA GENE; SENSITIVITY AND SPECIFICITY; STANDARD; TREATMENT FAILURE; TREATMENT OUTCOME; TRYPANOSOMA; ADOLESCENT; ADULT; AGED; CHILD; DEMOCRATIC REPUBLIC CONGO; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PARASITOLOGY;

PROTOZOAL DNA; RIBOSOME DNA; RNA 18S;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD; CEREBROSPINAL FLUID; CHILD; DEMOCRATIC REPUBLIC OF THE CONGO; DNA, PROTOZOAN; DNA, RIBOSOMAL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITOLOGY; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 18S; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN; YOUNG ADULT;

EID: 79952480164     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000972     Document Type: Article

References (38)

1. Simarro PP, Jannin J, Cattand P, (2008) Eliminating human African trypanosomiasis: Where do we stand and what comes next? PLoS Medicine 5: 174-180.
2. Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P, (2005) Options for the field diagnosis of human African trypanosomiasis. Clin Microbiol Rev 18: 133-146.
3. Brun R, Blum J, Chappuis F, Burri C, (2010) Human African trypanosomiasis. Lancet 375: 148-159.
4. Lejon V, Büscher P, (2005) Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health 10: 395-403.
5. World Health Organization (1998) Control and surveillance of African trypanosomiasis. WHO Technical Report Series 881: 1-113.
6. Deborggraeve S, Büscher P, (2010) Molecular diagnostics for sleeping sickness: where's the benefit for the patient? Lancet Infect Dis 10: 433-439.
7. Mumba Ngoyi D, Lejon V, Pyana P, Boelaert M, Ilunga M, et al. (2010) How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness? J Infect Dis 201: 453-463.
8. Matovu E, Mugasa CM, Ali Ekangu R, Deborggraeve S, Lubega GW, et al. (2010) Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. PLoS Negl Trop Dis 4: e737.
9. Woo PTK, (1970) The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Trop 27: 384-386.
10. Miézan TW, Meda AH, Doua F, Djé NN, Lejon V, et al. (2000) Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg 94: 293.
11. Büscher P, Mumba Ngoyi D, Kaboré J, Lejon V, Robays J, et al. (2009) Improved models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis 3: e471.
12. World Health Organization (2007) Recommendations of the informal consultation on issues for clinical product development for human African trypanosomiasis Geneva WHO/CDS/NTD/IDM/2007.1.
13. Radwanska M, Claes F, Magez S, Magnus E, Perez-Morga D, et al. (2002) Novel primer sequences for a polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am J Trop Med Hyg 67: 289-295.
14. Lutumba P, Meheus F, Robays J, Miaka C, Kande V, et al. (2007) Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis. Em Inf Dis 13: 1484-1490.
15. Truc P, Jamonneau V, Cuny G, Frézil JL, (1999) Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. Bull World Health Organ 77: 745-748.
16. Kyambadde JW, Enyaru JCK, Matovu E, Odiit M, Carasco JF, (2000) Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bull World Health Organ 78: 119-124.
17. Jamonneau V, Solano P, Garcia A, Lejon V, Djé N, et al. (2003) Stage determination and therapeutic decision in human African trypanosomiasis: value of PCR and IgM quantification on the cerebrospinal fluid of sleeping sickness patients in Cöte d'Ivoire. Trop Med Int Health 8: 589-594.
18. Pentreath VW, Owolabi AO, Doua F, (1992) Survival of Trypanosoma brucei brucei in cerebrospinal fluid. Ann Trop Med Parasitol 86: 29-34.
19. Doua F, Miézan TW, Sanon SR, Boa YF, Baltz T, (1996) The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg 55: 586-588.
20. Lejon V, Legros D, Savignoni A, Gastellu Etchegorry M, Mbulamberi D, et al. (2003) Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with Pentamidine. J Neuroimmunol 144: 132-138.
21. Gall Y, Woitag T, Bauer B, Sidibe I, McDermott J, et al. (2004) Trypanocidal failure suggested by PCR results in cattle field samples. Acta Trop 92: 7-16.
22. Jennings FW, Whitelaw DD, Holmes PH, Chizyuka HGB, Urquhart GM, (1979) The brain as a source of relapsing Trypanosoma brucei infection in mice after chemotherapy. J Parasitol 9: 381-384.
23. Miézan TW, Djé NN, Doua F, Boa F, (2002) Trypanosomose humaine africaine en Côte d'Ivoire: caractéristiques biologiques après traitement. A propos de 812 cas traités dans le foyer de Daloa (Côte d'Ivoire). Bull Soc Pathol Exot Fil 95: 362-365.
24. Mbati PA, Hirumi K, Inoue N, Situakibanza NH, Hirumi H, (1999) Towards developing a diagnostic regimen for the treatment follow-up of Trypanosoma brucei gambiense. Korean J Parasitol 37: 289-292.
25. Garcia A, Jamonneau V, Magnus E, Laveissière C, Lejon V, et al. (2000) Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitemic individuals in Côte d'Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health 5: 786-793.
26. Kirchhoff LV, (1998) Use of a PCR assay for diagnosing African trypanosomiasis of the CNS: a case report. Cent Afr J Med 44: 134-136.
27. Jamonneau V, Solano P, Cuny G, (2001) Utilisation de la biologie moleculaire dans le diagnostic de la trypanosomose humaine africaine. Méd Trop 61: 347-354.
28. Schifferli JA, Taylor S, (1989) Physiological and pathological aspects of circulating immune complexes. Kidney Int 35: 993-1003.
29. Kamei S, Takasu T, Morishima T, Mizutani T, (2004) Serial changes of intrathecal viral loads evaluated by chemiluminescence assay and nested PCR with aciclovir treatment in herpes simplex virus encephalitis. Internal Medicine 43: 796-801.
30. Pereira de Almeida PJL, (1999) Contributions to the diagnostic evaluation of the Polymerase Chain Reaction for the detection of Salivarian trypanosomes [dissertation]. Université Libre de Bruxelles, Brussels, Belgium.
31. Hecht MM, Nitz N, Araujo PF, Sausa AO, de Cássia Rosa A, et al. (2010) Inheritance of DNA transferred from American trypanosomes to human hosts. PLoS One 5: e9181.
32. Giroud C, Ottones F, Coustou V, Dacheux D, Biteau N, et al. (2009) Murine models for Trypanosoma brucei gambiense disease progression-from silent to chronic infections and early brain tropism. PLoS Negl Trop Dis 3: e509.
33. Nikolskaia OV, Kim YV, Kovbasnjuk O, Kim KJ, Grab DJ, (2006) Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier. Int J Parasitol 36: 513-519.
34. Stoppini L, Buchs P-A, Brun R, Muller D, Duport S, et al. (2000) Infection of organotypic slice cultures from rat central nervous tissue with Trypanosoma brucei brucei. Int J Med Microbiol 290: 105-113.
35. Claes F, Vodnala SK, Van Reet N, Boucher N, Lunden-Miguel H, et al. (2009) Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in sleeping sickness patients. PLoS Negl Trop Dis 3: e486.
36. Ngampo S, (1992) Suivi post-thérapeutique des malades trypanosomés à T.b. gambiense. Problèmes et perspectives [dissertation]. Instituut voor Tropische Geneeskunde, Antwerpen.
37. Robays J, Lefevre P, Lutumba P, Lubanza S, Kande Betu-Ku-Mesu V, et al. (2007) Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo. Trop Med Int Health 12: 290-298.
38. Njiru ZK, Mikosza ASJ, Matovu E, Enyaru JCK, Ouma JO, et al. (2008) African trypanosomiasis: Sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA. Int J Parasitol 38: 589-599.